Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation—A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials

@inproceedings{Chen2016EfficacyOS,
  title={Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation—A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials},
  author={Weijie Chen and Hang Liu and Zhiyu Ling and Yanping Xu and Jinqi Fan and Huaan Du and Peilin Xiao and Li Su and Zengzhang Liu and Xianbin Lan and Bernhard Zrenner and Yuehui Yin},
  booktitle={PloS one},
  year={2016}
}
BACKGROUND The efficacy of short-term antiarrhythmic drugs (AADs) use compared with no-AADs prescription after catheter ablation of atrial fibrillation (AF) in preventing atrial arrhythmia recurrence is uncertain. METHODS We searched PubMed, Embase, and the Cochrane Library through December 2015 to identify randomized controlled trials (RCTs) which evaluated the efficacy of short-term AADs use compared with no-AADs prescription after AF ablation in preventing atrial arrhythmia recurrence. The… CONTINUE READING
4
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Three-month lower-dose flecainide after catheter ablation of atrial fibrillation.

  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2014
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL